In January, Bo Bichette chose the Mets over seven years and roughly $200 million from Philadelphia.
He didn't choose security. He chose control.
This winter, he finds out what that control is worth.
The popular framing is a coin flip. Opt out or opt in. Stay or go. But that isn't how players and agents actually make these decisions, and it isn't how we should analyze it either.
Bichette isn't making one choice. He's walking a decision tree. Each branch closes off some outcomes and opens others, and the order of the questions matters as much as the answers.
So let's walk it the way his camp likely will. Node by node.
The Contract: Three One-Year Bets Stapled Together
The headline was three years, $126 million. The structure is something else entirely.
Bichette can opt out after 2026 or after 2027. Opting out comes with a $5 million buyout. And if he walks, the Mets cannot tag him with a qualifying offer, because he already turned one down from Toronto last November. (AP, Empire Sports Media)
Path | Guaranteed money | Next decision point | Market age |
|---|
Opt out now | $5M buyout + whatever the market pays | None (new deal) | Entering age-29 season |
Opt in | $42M for 2027 | Second opt-out after 2027 | Entering age-30 season |
Opt in twice | $84M through 2028 | None | Entering age-31 season |
The real number at risk isn't $84 million. It's about $79 million, net of the buyout.
And the honest way to think about it is narrower still. Opting in doesn't lock him into two years. It buys him one more year at $42 million and a second look at the same door.
That's the first thing most coverage misses. Opting in is not the conservative choice. It's the option-preserving choice.
Two Seasons in One Uniform
Bichette's final line reads like a disappointment: .260 average, .702 OPS, 18 home runs, 160 games, nearly all of them at a position he'd never played. (Heavy)
But a full-season line is an average of two very different players.
Split | AVG / OBP / SLG | wRC+ |
|---|
Opening Day through May | .219 / .275 / .308 | — |
June through mid-September | .298 / .346 / .464 | 124 |
Career baseline | .290 / .333 / .458 | 118 |
Source: MLB Trade Rumors, through mid-September
We tracked the early version in real time here. By mid-May, he'd gone hitless in 40% of his games and failed to collect an extra-base hit in 84% of them. That wasn't a slump. That was a hitter adjusting to a new league, a new position, and a new city all at once.
The June-forward player is just Bo Bichette. Same contact, same slug, same career shape.
In fairness to the skeptics, and in fairness to my own preseason case for him as a high-leverage bat, the finish wasn't clean. He grounded into four double plays in the final two weeks while hitting behind Juan Soto. (Amazin' Avenue) Small sample. Still a bad look on the last page of the résumé.
So which season does the market buy? That's the question the whole tree hangs on.
The Decision Tree, Node by Node
Five questions, asked in roughly the order an agent would ask them. The first two decide whether opting out is even rational. The last three decide whether it's wise.
Bichette opt-out decision tree · 5 nodes, 3 outcomes
Read it top to bottom. Opting out requires a yes at every gate. A single no anywhere sends him back to the Mets.
Node 1: Which Bo is the market pricing?
This is the gate. Everything else is downstream.
If front offices weight the last four months, Bichette is a 29-year-old infielder with a 118–124 wRC+ profile who can play short, third, and second. That player gets five or more years.
If they weight the full season, he's a league-average bat who just finished a year below his own standard. That player gets three years and opt-outs. Which is exactly the deal he already has.
The test is simple. Does a multi-year offer exist that beats $42 million now plus another run at free agency next winter? If not, the tree ends here. He opts in.
Node 2: What does the rest of the market look like?
This is the strongest branch for opting out.
The free-agent hitting class is thin, and Bichette would arguably be the best position player in it. (MLB Trade Rumors) Scarcity inflates prices.
More importantly, he comes with no qualifying offer this time. Last winter, Philadelphia would have surrendered draft picks and international pool money to sign him. (Central Bucks News) This winter, he's free. That widens the bidder pool to teams that were never in it.
Node 3: Is the calendar safe?
This is the branch nobody wants to talk about.
The collective bargaining agreement expires December 1. If talks stall and owners lock out the players, the free-agent market freezes. We saw it in 2021–22, when signings stopped cold from December to March.
A player who opts out into a lockout is unemployed, uninsured against injury, and waiting. A player who opts in has $42 million locked regardless of what happens at the bargaining table.
Labor risk doesn't make opting out wrong. It makes it more expensive.
Node 4: Does he want to be here?
In January, Bichette said his first priority was winning. The Mets missed the playoffs, fired their manager, and sold at the deadline.
That cuts toward leaving.
But the Mets just signed Andy Green to a three-year deal, and Bichette has spoken warmly about him. (MLB.com) He also has a full no-trade clause, a manager he trusts, and a year of third-base reps behind him. Comfort has value, especially for a player whose first two months in Queens were the hardest of his career.
Node 5: Is there a third door?
Opt in and opt out aren't the only exits.
The Mets could approach his camp before the deadline about a longer deal: tear up the remaining structure and add years. That's the outcome that serves both sides if they believe the June-forward player is the real one.
It's also the outcome Steve Cohen can afford to explore without much downside. The question is whether David Stearns wants to commit long-term to a converted third baseman who turns 29 in March.
Scoring the Branches
Lay the nodes side by side and the pattern is clear. The market pulls him out. The calendar and the clubhouse pull him back.
Node | Leans | Strength |
|---|
1. Which Bo is priced | Toss-up | Decisive |
2. Thin market, no QO | Opt out | Strong |
3. Labor calendar | Opt in | Strong |
4. Fit with Green and the Mets | Opt in | Moderate |
5. Extension door | Stay, on new terms | Depends on Stearns |
Here's how I'd weight the outcomes. These are my estimates, not anyone's reporting.
Outcome | RVH probability |
|---|
Opts in, revisits after 2027 | 45% |
Opts out, signs a long-term deal elsewhere | 30% |
Stays on a reworked, longer Mets deal | 25% |
The call: Bichette is a Met in 2027, roughly two times in three.
Not because $42 million is a lot of money. Because the opt-in branch keeps every other branch alive. He can still reach free agency at 30. He just does it with a full, normal season on the résumé instead of a split one, and without a labor fight hanging over the market.
The player who bet on control last January is most likely to keep betting on it.
What It Means for the Mets
The Mets don't control this decision. But they control how ready they are for either answer.
If he opts in, third base is settled for 2027 and the Mets get a full-season read on the June-forward hitter before deciding anything long-term. That's the Dodgers' playbook from Part 5 of Rethinking the Mets: buy information, preserve options.
If he opts out, $42 million comes off the 2027 books and the Mets get no draft pick in return. Third base reopens, and in a thin market, there may not be a clean replacement to buy.
The worst outcome isn't losing Bichette. It's being surprised by it.
Final Verdict
The coin-flip framing undersells how structured this decision really is.
The market says go. The calendar says wait. And the contract itself says he doesn't have to choose between them yet.
Bichette bought optionality last January. Expect him to use it the way smart money usually does: by keeping it.
